Evolent Health Inc (EVH) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Evolent Health Inc (EVH) has a cash flow conversion efficiency ratio of -0.002x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-984.00K) by net assets ($396.39 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See operational self-sufficiency of Evolent Health Inc to measure how many days the company can operate on defensive assets alone.
Evolent Health Inc - Cash Flow Conversion Efficiency Trend (2012–2025)
This chart illustrates how Evolent Health Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Evolent Health Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Evolent Health Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Taier Heavy Industry Co Ltd
SHE:002347
|
-0.014x |
|
Kolon Corp
KO:002020
|
-0.014x |
|
Shaanxi Xinghua Chemistry Co Ltd
SHE:002109
|
-0.015x |
|
Grand Pacific Petrochemical Corp
TW:1312
|
-0.035x |
|
IEI Integration Corp
TW:3022
|
0.073x |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
0.105x |
|
Shutterstock
NYSE:SSTK
|
0.062x |
|
Ooma Inc
NYSE:OOMA
|
0.067x |
Annual Cash Flow Conversion Efficiency for Evolent Health Inc (2012–2025)
The table below shows the annual cash flow conversion efficiency of Evolent Health Inc from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see EVH market cap.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $415.19 Million | $38.84 Million | 0.094x | +399.18% |
| 2024-12-31 | $1.00 Billion | $18.77 Million | 0.019x | -85.97% |
| 2023-12-31 | $1.07 Billion | $142.58 Million | 0.134x | +1093.40% |
| 2022-12-31 | $859.42 Million | $-11.55 Million | -0.013x | -124.06% |
| 2021-12-31 | $693.63 Million | $38.75 Million | 0.056x | +313.32% |
| 2020-12-31 | $619.60 Million | $-16.23 Million | -0.026x | +42.95% |
| 2019-12-31 | $929.05 Million | $-42.65 Million | -0.046x | -164.36% |
| 2018-12-31 | $1.19 Billion | $-20.65 Million | -0.017x | +35.02% |
| 2017-12-31 | $1.05 Billion | $-27.96 Million | -0.027x | +31.36% |
| 2016-12-31 | $912.11 Million | $-35.51 Million | -0.039x | -83.49% |
| 2015-12-31 | $934.58 Million | $-19.83 Million | -0.021x | -100.06% |
| 2014-12-31 | $-2.07 Million | $-75.09 Million | 36.277x | +8363.21% |
| 2013-12-31 | $31.04 Million | $-13.63 Million | -0.439x | +82.12% |
| 2012-12-31 | $5.20 Million | $-12.77 Million | -2.455x | -- |
About Evolent Health Inc
Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated value-based care platform for health plan administration and management. It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, analytics an… Read more